ASPAC III Acquisition Corp. Reports Material Agreement
Ticker: ASPCR · Form: 8-K · Filed: Jan 27, 2025 · CIK: 1890361
Sentiment: neutral
Topics: spac, definitive-agreement
TL;DR
ASPAC III Acquisition Corp. signed a material deal on Jan 24th, filing it today.
AI Summary
ASPAC III Acquisition Corp. filed an 8-K on January 27, 2025, reporting a material definitive agreement entered into on January 24, 2025. The filing also includes financial statements and exhibits. ASPAC III Acquisition Corp. is a blank check company incorporated in the British Virgin Islands.
Why It Matters
This filing indicates a significant development for ASPAC III Acquisition Corp., likely related to its business combination or acquisition plans as a SPAC.
Risk Assessment
Risk Level: medium — As a SPAC, the company's future success is highly dependent on completing a successful business combination, which carries inherent risks.
Key Players & Entities
- ASPAC III Acquisition Corp. (company) — Registrant
- January 24, 2025 (date) — Date of material definitive agreement
- January 27, 2025 (date) — Date of report
FAQ
What is the nature of the material definitive agreement entered into by ASPAC III Acquisition Corp. on January 24, 2025?
The filing does not specify the details of the material definitive agreement, only that one was entered into on January 24, 2025.
What is the primary business of ASPAC III Acquisition Corp.?
ASPAC III Acquisition Corp. is a blank check company, as indicated by its SIC code [6770].
When was ASPAC III Acquisition Corp. incorporated and where?
ASPAC III Acquisition Corp. was incorporated in the British Virgin Islands, with its fiscal year ending on December 31.
What was the former name of ASPAC III Acquisition Corp. and when did the name change occur?
The former name was SPAC III Acquisition Corp., and the name change occurred on October 25, 2021.
What are the components of the units offered by ASPAC III Acquisition Corp.?
The units consist of one Class Ordinary Share with no par value and one right to receive one-tenth of one Class Ordinary Share.
Filing Stats: 2,746 words · 11 min read · ~9 pages · Grade level 20 · Accepted 2025-01-27 17:00:21
Key Financial Figures
- $200,000,000 — olders of equity awards of Bioserica is $200,000,000, which will be paid entirely in stock,
- $10.00 — y shares of the Purchaser at a price of $10.00 per share, or equity awards with respec
Filing Documents
- ea0228397-8k425_aspac3.htm (8-K) — 75KB
- ea022839701ex10-1_aspac3.htm (EX-10.1) — 500KB
- 0001213900-25-007066.txt ( ) — 916KB
- aspcu-20250124.xsd (EX-101.SCH) — 4KB
- aspcu-20250124_def.xml (EX-101.DEF) — 27KB
- aspcu-20250124_lab.xml (EX-101.LAB) — 37KB
- aspcu-20250124_pre.xml (EX-101.PRE) — 25KB
- ea0228397-8k425_aspac3_htm.xml (XML) — 7KB
01 Entry into Material Definitive Agreement
Item 1.01 Entry into Material Definitive Agreement. On January 24, 2025, A SPAC III Acquisition Corp. (the "Company" or the "Parent") announced that it executed an Agreement with Bioserica International Limited ("Bioserica") as further described below (the "Agreement"). Bioserica is in the business of researching and developing, manufacturing, marketing and sales of bio-based antimicrobial materials. The Agreement is intended to express a mutual indication of interest and remains subject, in all respect, to the execution of definitive agreements ("Definitive Agreements"). The Agreement provides the following terms, which are subject to the execution of Definitive Agreements in all respects: Reincorporation Merger Upon the closing of the transactions contemplated in the Agreement, the Parent will be merged with and into a to-be-formed British Virgin Islands business company formed for the sole purpose of this transaction (the "Purchaser"), the separate corporate existence of the Parent will cease and Purchaser will continue as the surviving corporation (the " Reincorporation Merger "). In connection with the Reincorporation Merger, each of the Parent's issued and outstanding shares will be converted into an equivalent share of Purchaser: Immediately prior to the Reincorporation Effective Time, each Parent's unit shall be separated automatically into its constituent securities (e.g. One Parent Unit into one Parent Class A Ordinary share and one-tenth (1/10) of one Parent Class A ordinary Share), as applicable; Each Parent's Ordinary Share will be converted automatically into one corresponding share of Purchaser's Class A Ordinary Share; Each Parent Right shall be converted automatically into one-tenth (1/10) of one Parent Class A Ordinary Share, which shall be converted automatically into Purchaser Class A Ordinary Share at the Reincorporation Effective Time, in accordance with the terms thereof; At the Reincorporation Effective Time, every issued and out
Forward-Looking Statements
Forward-Looking Statements Certain statements made in this Current Report are forward-looking statements. When used in this Current Report, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include: the inability of the Company to enter into a definitive agreement with respect to an initial business combination within the time provided in the Company's amended and restated memorandum and articles of association; performance of the potential target company's business; the risk that the approval of the shareholders of the Company for the Potential Business Combination is not obtained; failure to realize the anticipated benefits of the Potential Business Combination, including as a result of a delay in consummating the Potential Business Combination; the level of redemptions made by the Company's shareholders and its impact on the amount of funds available in the Company's trust account to complete an initial business combination; and those factors discussed in the Annual Report under the heading "Risk Factors," and other documents of the Company filed, or to be filed, with the SEC. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as req
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit Number Description 10.1 Agreement dated January 24, 2025 by and among A SPAC III Acquisition Corp. and BIOSERICA INTERNATIONAL LIMITED. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 5 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. A SPAC III ACQUISITION CORP. Dated: January 27, 2025 By: /s/ Claudius Tsang Name: Claudius Tsang Title: Chief Executive Officer and Chief Financial Officer 6